PMID- 25303484 OWN - NLM STAT- MEDLINE DCOM- 20150708 LR - 20220409 IS - 1945-7197 (Electronic) IS - 0021-972X (Linking) VI - 100 IP - 1 DP - 2015 Jan TI - Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. PG - E96-100 LID - 10.1210/jc.2014-2300 [doi] AB - CONTEXT: Betatrophin has recently attracted increasing interests as a potential beta-cell regenerative therapy in diabetes. However, differences in betatrophin profiles in patients with type 2 diabetes mellitus (T2DM) remain unclear. OBJECTIVE: The objective of the study was to examine circulating betatrophin levels in subjects with different glucose tolerance status and its correlation with insulin resistance. DESIGN, SETTING, AND PARTICIPANTS: Serum betatrophin levels were measured using an ELISA in age-, sex-, body mass index-, and blood lipid-matched subjects with normal glucose tolerance (n = 137), isolated impaired fasting glucose (n = 69), isolated impaired glucose tolerance (n = 120), and newly diagnosed T2DM (n = 112) from the Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal study. RESULTS: Serum betatrophin levels were elevated in patients with T2DM compared with subjects with normal glucose tolerance, isolated impaired fasting glucose, or isolated impaired glucose tolerance (798.6 +/- 42.5 vs 692.7 +/- 29.0, P < .05, vs 682.7 +/- 43.0, P < .05, vs 646.8 +/- 34.3 pg/mL, P < .01). Betatrophin levels positively correlated with the index of homeostasis model assessment of insulin resistance (partial r = 0.11); inversely correlated with quantitative insulin sensitivity check index (partial r = -0.11), the Gutt insulin sensitivity index (partial r = -0.12), and the Matsuda insulin sensitivity index (partial r = -0.11) after controlling for age, sex, body mass index, and blood lipid in all participants (all values of P < .05). CONCLUSION: Circulating betatrophin levels are increased in patients with T2DM and associated with indexes of insulin resistance. FAU - Chen, Xi AU - Chen X AD - Division of Endocrinology (X.C., P.L., W.H., J.Z., Y.Y., Z.L., J.X., S.S., T.D., X.S., X.Z., S.H., G.Y., M.Z., X.Y.), Department of Internal Medicine, Division of Cardiology (Le.L., D.W.), Department of Internal Medicine, Department of Ophthalmology (H.Z.), Tongji Hospital, and Department of Nutrition and Food Hygiene (Li.L.), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, People's Republic of China. FAU - Lu, Puhan AU - Lu P FAU - He, Wentao AU - He W FAU - Zhang, Jianhua AU - Zhang J FAU - Liu, Lei AU - Liu L FAU - Yang, Yan AU - Yang Y FAU - Liu, Zhelong AU - Liu Z FAU - Xie, Junhui AU - Xie J FAU - Shao, Shiying AU - Shao S FAU - Du, Tingting AU - Du T FAU - Su, Xianghui AU - Su X FAU - Zhou, Xinrong AU - Zhou X FAU - Hu, Shuhong AU - Hu S FAU - Yuan, Gang AU - Yuan G FAU - Zhang, Muxun AU - Zhang M FAU - Zhang, Hong AU - Zhang H FAU - Liu, Liegang AU - Liu L FAU - Wang, Daowen AU - Wang D FAU - Yu, Xuefeng AU - Yu X LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (ANGPTL8 protein, human) RN - 0 (Angiopoietin-Like Protein 8) RN - 0 (Angiopoietin-like Proteins) RN - 0 (Peptide Hormones) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Angiopoietin-Like Protein 8 MH - Angiopoietin-like Proteins MH - Diabetes Mellitus, Type 2/*blood MH - Female MH - Glucose Intolerance/*blood MH - Glucose Tolerance Test MH - Humans MH - Insulin Resistance/*physiology MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Peptide Hormones/*blood MH - Prediabetic State/*blood EDAT- 2014/10/11 06:00 MHDA- 2015/07/15 06:00 CRDT- 2014/10/11 06:00 PHST- 2014/10/11 06:00 [entrez] PHST- 2014/10/11 06:00 [pubmed] PHST- 2015/07/15 06:00 [medline] AID - 10.1210/jc.2014-2300 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2015 Jan;100(1):E96-100. doi: 10.1210/jc.2014-2300.